Bedfont Scientific, based in Harrietsham Kent, successfully passes another FDA inspection.
Bedfont Scientific, a local medical device manufacturer specialising
in breath analysis, is pleased to announce that the US Food and Drug
Administration (FDA) has completed a successful inspection at its
premises. The audit found Bedfont to be compliant with Good
Manufacturing Practice (GMP), which means their products are
manufactured to the highest quality which is essential when you’re
providing technology that saves people’s lives.
Louise Bateman, QA & RA Manager at Bedfont Scientific, says,
“We are really pleased the FDA follow-up audit went well and all previous observations were closed out. With this outcome, it shows we are working as a compliant company to FDA standards and are able to continue to provide high-quality products to the USA. We look forward to working with the FDA in the future and to continue building on our relationship with them.”
General Manager, Jason Smith, adds,
“Bedfont’s aim for the future with this clean bill of health is to continue with our scientific contributions to health, including research and development into new medical breath analysis applications, to help save peoples’ lives, one breath at a time.”